Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Methods for identifying a subject at increased risk for developing AMD by determining the presence of protective genotypes at either the BF/C2 locus and at the CFH locus. More
Opticin has been found to exhibit anti-angiogenic (blood vessel formation) effects on a range of cell lines from different cancers More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 392 pages - $1,495
Sep 2011 - 77 pages - $3,500
Feb 2011 - 44 pages - $500
Dec 2010 - 50 pages - $2,000
Dec 2010 - 91 pages - $500
Apr 2011 - 114 pages - $500
Aug 2011 - 195 pages - $500
Sep 2011 - 208 pages - $500
Oct 2011 - 35 pages - $500
Dec 2010 - 30 pages - $500
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us